Growth of the Cell Isolation Market is the Increasing Government Funding in Biomedical Research

The global cell isolation market accounted for $4.6 billion revenue in 2017, and it is expected to attain a CAGR of 18.8% during the forecast period (2018–2023). The demand for cell isolation products and services is increasing due to the rise in requirement for biopharmaceuticals, growing research activities in personalized medicine, and increasing government funding for research. Cell isolation is the separation of one or multiple types of cells from a heterogenous cell population.

It has become an integral step in biological research, and routine diagnosis and treatment of certain diseases. Some cell types, such as blood cells, naturally exist in a separated form and thus can be isolated by employing centrifugation, whereas some others exist as solid tissues that require specific techniques to isolate the individual cell type. The global cell isolation market is witnessing growth owing to the rising demand for biopharmaceutical products derived from natural sources, such as plants, animals, and humans, that are easier to manufacture than conventional pharmaceuticals.

Biopharmaceuticals include monoclonal antibodies, recombinant proteins, and biosimilars, the manufacturing of which starts with cell separation and isolation techniques. Biopharmaceuticals are heavily employed to treat chronic conditions, mostly cancer, such as chronic myelogenous leukemia and melanoma. They are also used in various diagnostic assays, such as enzyme-linked immunosorbent assays (ELISA) and radioimmunoassay (RIA). Another major contributing factor to the growth of the cell isolation is the increasing government funding in biomedical research.

People in developed countries are shifting toward personalized medicine, owing to their awareness and means to afford personalized treatment, as they can now avail of several reimbursement schemes. The advent of new technologies, such as genetic mapping via next-generation sequencing, which helps in identifying the gene responsible for a specific disease, is boosting the personalized medicine domain. This growth in the personalized medicine domain is impacting the cell isolation market positively.

The market is segmented by product, application, cell type, end user, geography, and technique. The product segment is categorized into instruments and consumables. During the forecast period, the consumables category is expected to attain the faster growth at a CAGR of 19.3%. This increase is attributed to the rising demand for various kits, media, beads, sera, reagents, and disposables that are required during the cell isolation process. On the basis of application, the cell isolation market is subdivided into tissue regeneration, stem cell research, cancer research, in-vitro diagnostics and therapeutics, and biomolecule isolation.

Some of the key players operating in the cell isolation industry are Terumo Corporation, General Electric Company, pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG, Danaher Corporation, Merck KGaA, Miltenyi Biotec GmbH, and Becton, Dickinson and Company.